Trent Local Children's Research Network

If you can read this, You need to upgrade your Flash Player. Click HERE to get the latest version.

Home Home Page Events Children Young People Adults Staff and Professionals Our offices Google map Newsletters Contact Us	Events View All Events Road Shows Add yourself to our contacts database Conference 2008 Conference 2009 GCP Training Conference 2010 Children's Clinical Research Facility Research Forum Newsletters Contact Us	Children What we do Why we exist Who we are Where we work How we work Research Process Dino Match Game Dino Peg Game Get involved Links to other websites Downloads Contact	Young People Who we are Why we exist What we do Where we work How we work Research Process Get involved Links to other websites Downloads Contact	Adults Who we are Why we exist What we do Where we work How we work Research Process Get involved Our offices Links to other websites Staff Vacancies Downloads Contact	Professionals Who we are Why we exist What we do Where we work How we work Research Process Portfolio Get involved Contact us Links to other websites Staff Vacancies Downloads Contact

Winter 2010 Newsletter now available online

The latest edition of the TLC-RN newsletter is now available by clicking on the link below.

More Information

Flexibility and Sustainability Funding

Applications are invited for FSF funding from the TLCRN.

More Information

Children & Young Persons Advisory Group

'Want to join a group of young people who advise on research into medicines for children & young people?'

More Information

Why we exist

Most medicines were developed for adults because:

There are many more adults than young people in the world, so medicines designed for adults are used in much larger quantities, and so they are more economical for manufacturers to make and sell.

In many cases, manufacturers who want to develop new medicines can try them out on adult volunteers to make sure that they are safe and effective. They can advertise in newspapers, on buses, and elsewhere, for adult volunteers. Testing on young people raises greater ethical issues, which has hindered development.

If you can read this, You need to upgrade your Flash Player. Click HERE to get the latest version.

Consequently:

Sometimes in the past, doctors who needed to treat young people children faced a dilemma.

They might have used a medicine off-label; for example, where the dose of a medicine had been scientifically tested, but only for adults, when the doctors might have prescribed lower doses for young people, by using their professional skill. Or, the doctors might have prescribed a medicine to treat a young person's illness for which it had not been scientifically tested, but it was well-known to be safe and effective.

They might have used a medicine in an unlicensed way; for example, by grinding tablets into a powder and mixing it with a liquid, to make it easier to swallow.

You can read more about off-label and unlicensed medicines by clicking here.

But now:

There is a new European legal requirement to test medicines on children and young people before they can be licensed for them. This raises questions of costs and ethics.

As an incentive for drug companies to fund the scientific research into medicines for children and young people, they are allowed extended patent protection to help them recover their research costs.

Our role as part of the UK National Institute for Health Research includes helping manufacturers and NHS researchers carry out research ethically, introducing them to young patients.

Please click here to find more about what we do.

Homepage	Sitemap	Accessibility	Search TLCRN: